CTSO · Cytosorbents Corp · Fails to Deliver
$5.35
+0.03 (+0.56%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“approximately $4.4 million in unrestricted cash and cash equivalents and $1.5 million of non-current restricted cash which may not be sufficient to fund the Company's operations beyond the next twelve months from the issuance of these condensed consolidated financial statements. These cash and restricted cash balances considered with our historical and expected future cash used in operations, notwithstanding our Strategic Workforce and Cost Reduction Plan and the impact of the Amended Loan and Security Agreement, raises substantial doubt about the Company's ability to continue as a going concern within twelve months after the date that the accompanying condensed consolidated financial statements are issued.”View the 10-Q filed Aug 6, 2026
Market Cap
$16.72M
Shares
3.14M
Volume · Oct 21
39.52K
Avg daily vol (30 sessions)
44.8K
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-25 | 7 | $4.35 | $30 |
| 2026-09-24 | 185 | $5.02 | $929 |
| 2026-09-17 | 96 | $5.73 | $550 |
| 2026-09-16 | 65 | $6.06 | $394 |
| 2026-09-15 | 751 | $5.75 | $4,318 |
| 2026-09-14 | 4,859 | $6.41 | $31,146 |
| 2026-09-10 | 856 | $6.33 | $5,418 |
| 2026-09-09 | 481 | $6.76 | $3,252 |
| 2026-09-02 | 11 | $0.34 | $4 |
| 2026-09-01 | 1,646 | $0.34 | $560 |
| 2026-08-26 | 2,737 | $0.36 | $985 |
| 2026-08-14 | 3,929 | $0.36 | $1,414 |
| 2026-07-29 | 1 | $0.37 | $0 |
| 2026-07-28 | 78 | $0.36 | $28 |
| 2026-07-23 | 7,838 | $0.38 | $2,978 |
Showing 1–15 of 15 settlements